Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.

Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ, Heinzelmann M, Kalish LH, Bali A, Kench JG, Edwards LS, Vanden Bergh PM, Hacker NF, Sutherland RL, O'Brien PM.

Clin Cancer Res. 2004 Jul 1;10(13):4427-36.

PMID:
15240533
[PubMed - indexed for MEDLINE]
Free Article
2.

Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.

Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.

Int J Gynecol Cancer. 2009 Jul;19(5):860-6. doi: 10.1111/IGC.0b013e3181a8331f.

PMID:
19574774
[PubMed - indexed for MEDLINE]
3.

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD, Gregoire L, Schwartz DR, Cho KR, Morin PJ.

Clin Cancer Res. 2003 Jul;9(7):2567-75.

PMID:
12855632
[PubMed - indexed for MEDLINE]
Free Article
4.

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.

Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr.

Clin Cancer Res. 2004 May 15;10(10):3291-300.

PMID:
15161682
[PubMed - indexed for MEDLINE]
Free Article
5.

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG.

Gynecol Oncol. 2006 Nov;103(2):483-8. Epub 2006 May 6.

PMID:
16678891
[PubMed - indexed for MEDLINE]
6.

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.

Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S.

Int J Cancer. 2004 Oct 20;112(1):14-25.

PMID:
15305371
[PubMed - indexed for MEDLINE]
7.

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.

Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD.

Eur J Cancer. 2010 Mar;46(5):944-53. doi: 10.1016/j.ejca.2009.12.019. Epub 2010 Jan 8.

PMID:
20060709
[PubMed - indexed for MEDLINE]
8.

Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.

Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.

Gynecol Oncol. 2006 Nov;103(2):405-16. Epub 2006 May 24.

PMID:
16725184
[PubMed - indexed for MEDLINE]
9.

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Kim JH, Herlyn D, Wong KK, Park DC, Schorge JO, Lu KH, Skates SJ, Cramer DW, Berkowitz RS, Mok SC.

Clin Cancer Res. 2003 Oct 15;9(13):4782-91.

PMID:
14581349
[PubMed - indexed for MEDLINE]
Free Article
10.

Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.

Choi YL, Kim J, Kwon MJ, Choi JS, Kim TJ, Bae DS, Koh SS, In YH, Park YW, Kim SH, Ahn G, Shin YK.

Histol Histopathol. 2007 Nov;22(11):1185-95.

PMID:
17647191
[PubMed - indexed for MEDLINE]
11.

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

PMID:
17332284
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Claudin-7 expression in human epithelial ovarian cancer.

Tassi RA, Bignotti E, Falchetti M, Ravanini M, Calza S, Ravaggi A, Bandiera E, Facchetti F, Pecorelli S, Santin AD.

Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1262-71. doi: 10.1111/j.1525-1438.2008.01194.x. Epub 2008 Feb 19.

PMID:
18298564
[PubMed - indexed for MEDLINE]
14.

The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.

Zecchini S, Bianchi M, Colombo N, Fasani R, Goisis G, Casadio C, Viale G, Liu J, Herlyn M, Godwin AK, Nuciforo PG, Cavallaro U.

Cancer Res. 2008 Feb 15;68(4):1110-8. doi: 10.1158/0008-5472.CAN-07-2897.

PMID:
18281486
[PubMed - indexed for MEDLINE]
Free Article
15.

Overexpression of CEACAM6 in borderline and invasive mucinous ovarian neoplasms.

Litkouhi B, Litkouhi B, Fleming E, Welch WR, Berkowitz RS, Birrer MJ, Mok SC.

Gynecol Oncol. 2008 May;109(2):234-9. doi: 10.1016/j.ygyno.2008.01.031. Epub 2008 Mar 10.

PMID:
18331757
[PubMed - indexed for MEDLINE]
16.

Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.

Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.

Clin Cancer Res. 2004 Aug 1;10(15):5168-77.

PMID:
15297421
[PubMed - indexed for MEDLINE]
Free Article
17.

Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression.

Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ.

Gynecol Oncol. 2002 Jul;86(1):69-78.

PMID:
12079303
[PubMed - indexed for MEDLINE]
18.

Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Têtu B, Bairati I, Bachvarov D.

Mol Oncol. 2011 Oct;5(5):438-53. doi: 10.1016/j.molonc.2011.07.003. Epub 2011 Jul 26.

PMID:
21856257
[PubMed - indexed for MEDLINE]
Free Article
19.

Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.

Dahiya N, Becker KG, Wood WH 3rd, Zhang Y, Morin PJ.

PLoS One. 2011;6(7):e22119. doi: 10.1371/journal.pone.0022119. Epub 2011 Jul 15.

PMID:
21789222
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.

Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA.

Clin Cancer Res. 2003 May;9(5):1710-20.

PMID:
12738725
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk